Is K-ras Gene Mutation a Prognostic Factor for Colorectal Cancer

Mutations in K-ras and Epidermal Growth Factor Receptor Expression in Korean Patients With Stages III and IV Colorectal Cancer

(2011) Won-Suk Lee et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients

(2011) Hong Shen   WORLD JOURNAL OF GASTROENTEROLOGY

The prognostic value of c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer

(2010) Mostafa M. El-Serafi et al.   CANCER

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer

(2010) Inti Zlobec et al.   INTERNATIONAL JOURNAL OF CANCER

Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations

(2010) Ezzeldin M. Ibrahim et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Genetic alterations of K-ras may reflect prognosis in stage III colon cancer patients below 60 years of age

(2010) Wataru Onozato et al.   JOURNAL OF SURGICAL ONCOLOGY

KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

Molecular Genetic Changes Associated With Colorectal Carcinogenesis Are Not Prognostic for Tumor Regression Following Preoperative Chemoradiation of Rectal Carcinoma

(2009) N. Peter Zauber et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer

(2009) Winder   ONCOLOGY REPORTS

KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy

(2009) Jochen Gaedcke et al.   RADIOTHERAPY AND ONCOLOGY

Systemic Treatment of Colorectal Cancer

(2008) Brian M. Wolpin et al.   GASTROENTEROLOGY

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers

(2008) Ludovic Barault et al.   INTERNATIONAL JOURNAL OF CANCER

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY